Intercept cuts 25% of workforce after NASH rejection from FDA esagonowsky Tue, 09/01/2020 – 15:14

AstraZeneca shells out up to $60M to reserve more coronavirus shot capacity with Oxford Biomedica kblankenship Tue, 09/01/2020 […]

HHS bids out massive $250M ad campaign to put hopeful spin on coronavirus pandemic: report bbulik Tue, 09/01/2020 […]

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman esagonowsky Tue, 09/01/2020 – 11:30

Scientists have taken a significant step forward in the search to find effective new drug candidates for the […]

Florida State University researchers have developed a new material that could be used to make flexible X-ray detectors […]

Mitochondria are the power plants of our cells and play an important role in providing energy for normal […]

The EC has cleared its use for the treatment of extensive-stage small cell lung cancer

The Phase II/III COMET-ICE study will assess safety and efficacy of antibody treatment in preventing hospitalisation due to […]

Clinical development of AZD1222 is progressing globally with late-stage clinical trials ongoing in the UK, Brazil and South […]